J 1997

T cell activity and cytokine production in X-linked agammaglobulinemia: Implications for vaccination strategies

PLEBANI, A., MB. FISCHER, A. MEINI, M. DUSE, Vojtěch THON et. al.

Basic information

Original name

T cell activity and cytokine production in X-linked agammaglobulinemia: Implications for vaccination strategies

Name in Czech

T buněčná aktivita a cytokinová produkce u X vázané agamaglobulinemie: důsledky pro vakcinační strategii

Authors

PLEBANI, A. (380 Italy), MB. FISCHER (40 Austria), A. MEINI (380 Italy), M. DUSE (380 Italy), Vojtěch THON (203 Czech Republic, guarantor) and MM. EIBL (40 Austria)

Edition

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 1018-2438

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.721

RIV identification code

RIV/00216224:14110/97:00035798

Organization unit

Faculty of Medicine

UT WoS

A1997XR99700014

Keywords (in Czech)

XLA; vakcinace

Keywords in English

X linked agammaglobulinemia; vaccine; cytokines; cell mediated immunity

Tags

International impact, Reviewed
Změněno: 26/6/2009 00:17, prof. MUDr. Vojtěch Thon, Ph.D.

Abstract

V originále

In the 5 X-linked agammaglobulinelnia (XLA) patients studied we show that memory T cells are present and that T lymphocytes proliferate normally to mitogens, monoclonal antibodies and, in particular, to recall antigens demonstrating normal in vivo T cell priming despite the absence of B cells. Furthermore, in vitro T cell activation in response to both T cell receptor-independent and T-cell receptor-dependent signals leads to a pattern of cytokine production characteristic of primed T cells and necessary for normal T cell function. These data are in good agreement with results obtained in gene-targeted mice and further support the concept that the absence of B cells does not impair induction of in vivo T cell memory and effector function which is generally considered to be of great importance in conferring protection against viral infections. Thus, while there is no risk of inducing infections in XLA patients by administering vaccines containing killed viruses or recombinant viral proteins, stimulation of T cell immunity by such vaccines may be of potential benefit particularly in the defense against infections with viruses such as the hepatitis B virus to which hypogammaglobulinemic patients are particularly exposed.

In Czech

T buněčná aktivita a cytokinová produkce u X vázané agamaglobulinemie: důsledky pro vakcinační strategii.